Attached files
| file | filename |
|---|---|
| EX-99.1 - BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC | valordeedoftrust.htm |
| EX-99.2 - BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC | valorpromissorynote.htm |
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A-1
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 28, 2010
BioMedical Technology Solutions Holdings, Inc.
(Exact name of registrant as specified in its charter)
Colorado | 000-52652 | 26-3161860 |
(State or other jurisdiction of incorporation or organization) | (Commission file number) | (IRS Employer Identification No.) |
9800 Mt Pyramid Court # 250
Englewood, CO 80112
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (303) 653-0100
_ _CET Services, Inc.
12503 Euclid Dr. #30, Centennial, Colorado 80111
(Former name or former address, if changed since last report)
___ | Written communications pursuant to Rule 425 under the Securities Act |
___ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act |
___ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
___ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
ITEM 8.01 | OTHER EVENTS |
ITEM 2.03 | CREATION OF DIRECT FINANCIAL OBLIGATION |
On October 1, 2009, the Company and its wholly-owned subsidiary, BMTS Properties, Inc., executed a promissory note in favor of Valor Invest, Ltd., a British Virgin Islands company (“Valor’) in the principal amount of $200,000 (the “Note”). The Note was and is secured by a second priority Deed of Trust encumbering real property owned by BMTS Properties.
The Note matured and became due and payable on February 28, 2010. As a result of the Company’s default under the Note, Valor has commenced a civil action against the Company and BMTS Properties in the Douglas County District Court.
The Company is in active discussions with Valor and its legal counsel concerning the matter; however as of the date hereof, no resolution has been reached. The Company currently lacks the working capital to pay the Note. No prediction can be made regarding the outcome of the matter.
ITEM 9.01 | FINANCIAL STATEMENTS AND EXHIBITS |
99.1 | Deed of Trust |
99.2 | Promissory Note |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS, INC. | ||
Date: April _5, 2010 | By: _/s/ Donald G. Cox ___________ Donald G. Cox, President | |
3